Recent advances in cancer immunology have led to a better understanding of the role of the tumor microenvironment (TME) in tumor initiation, progression, and metastasis. Tumors can occur at many locations within the body and coevolution between malignant tumor cells and non-malignant cells sculpts the TME at these sites. It has become increasingly clear that there are specific differences of the TMEs at different anatomical locations, and these tissue-specific TMEs regulate tumor growth, determine metastatic progression, and impact on the outcome of therapy responses. Herein, we review the scientific advances in understanding tissue-specific TMEs, discuss their impact on immunotherapeutic response, and assess the current clinical knowledge in this emerging field. A deeper understanding of the tissue-specific TME will help to develop effective immunotherapies against tumors and their metastases and assist in predicting clinical outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797771 | PMC |
| http://dx.doi.org/10.3389/fimmu.2018.00070 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation.
Cancer Cell
October 2024
Biomedical Pioneering Innovation Center (BIOPIC), Academy for Advanced Interdisciplinary Studies, and School of Life Sciences, Peking University, Beijing 100871, China. Electronic address:
Article Synopsis
- This study analyzes fibroblast cells from 517 human samples across 11 tissue types, revealing different fibroblast subpopulations that change in response to inflammation and cancer.
- Researchers identified four distinct myofibroblast subpopulations, noting that some, like LRRC15 and MMP1, promote tumor growth while others, such as PI16, might have anti-tumor effects.
- The findings improve our understanding of fibroblast roles in tumors and hint at new therapeutic strategies targeting specific fibroblast types to enhance cancer treatment outcomes.
Designer self-assembling peptides form the entangled nanofiber networks in hydrogels by ionic-complementary self-assembly. This type of hydrogel has realistic biological and physiochemical properties to serve as biomimetic extracellular matrix (ECM) for biomedical applications. The advantages and benefits are distinct from natural hydrogels and other synthetic or semisynthetic hydrogels.
View Article and Find Full Text PDFObjectives: Investigation of variable response rates to cancer immunotherapies has exposed the immunosuppressive tumor microenvironment (TME) as a limiting factor of therapeutic efficacy. A determinant of TME composition is the tumor location, and clinical data have revealed associations between certain metastatic sites and reduced responses. Preclinical models to study tissue-specific TMEs have eliminated genetic heterogeneity, but have investigated models with limited clinical relevance.
View Article and Find Full Text PDFSuppressing immunotherapy by organ-specific tumor microenvironments: what is in the brain?
Cell Biosci
October 2019
Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX USA.
Recent breakthroughs in cancer immunotherapy have led to curative efficacy and significantly prolonged survival in a subset of patients of multiple cancer types; and immunotherapy has become the newest pillar of cancer treatment in addition to surgery, chemotherapy, radiotherapy and precision targeted therapies. In the metastatic disease setting, responses to immunotherapy are heterogeneous depending on the metastatic organ sites. The tissue-specific immuno-biology in the tumor microenvironments (TMEs) contributes to the differential therapeutic responses.
View Article and Find Full Text PDFTissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses.
Front Immunol
February 2019
Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.
Recent advances in cancer immunology have led to a better understanding of the role of the tumor microenvironment (TME) in tumor initiation, progression, and metastasis. Tumors can occur at many locations within the body and coevolution between malignant tumor cells and non-malignant cells sculpts the TME at these sites. It has become increasingly clear that there are specific differences of the TMEs at different anatomical locations, and these tissue-specific TMEs regulate tumor growth, determine metastatic progression, and impact on the outcome of therapy responses.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!